Note: Ingredients listed on restricted chemical lists
EC/CAS
215-149-9/1306-25-8
Name of the chemical
Cadmium telluride (CdTe)
Concentration
<= 100 %
General Information
Product name
Cadmium Telluride
CAS No.
1306-25-8
1.2.1 Relevant identified uses
Laboratory chemicals, Industrial & for professional use only
Emergency telephone
+91 11 49404040
Icons in SDS
Company Information
company name
Central Drug House (P) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
care@cdhfinechemical.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332, H410
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Warning
Hazard statements
H302 + H312 + H332 Harmful if swallowed, in contact with skin or if inhaled H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P391 Collect spillage.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Acute aquatic toxicity (Category 1), H400 Chronic aquatic toxicity (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16.
